对MET酸化对特波提尼布结合的影响的生物物理和结构性表征
Ulrich Grädler1, Daniel Schwarz1, Ansgar Wegener1
1The Healthcare Business of Merck KGaA, Darmstadt, Germany.
The Journal of biological chemistry
|October 8, 2023
概括
德波提尼布 (Tepotinib) 是一种药物.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 氨酸激酶的MET受体对细胞生长和转移至关重要.
- MET失调驱动癌症的进展.
- 德波提尼布是一种经批准的MET抑制剂,用于特定的非小细胞肺癌.
研究的目的:
- 为了研究MET激活循环 (A-loop) 构造如何影响tepotinib结合.
- 阐明tepotinib与MET激酶域变异的相互作用的结构基础.
主要方法:
- 蛋白质结晶学用于确定复杂结构.
- 生物物理测定 (SPR,DSF) 来评估结合动力学和稳定性.
- 质谱法用于分析蛋白质修饰.
- 光交叉相关谱学用于目标参与研究.
主要成果:
- 与MET突变物结合的特波提尼布的晶体结构显示了改变的A环形状.
- 降低了与A循环调制和中断相互作用相关的tepotinib停留时间.
- 影响酸化部位的突变或Y1230相互作用影响了结合亲和力.
- 在细胞上下文中确认了目标参与.
结论:
- MET A-循环形状是特波提尼布结合亲和力和停留时间的关键决定因素.
- 了解这些结构决定因素可以为下一代MET抑制剂的开发提供信息.
- 这项研究提供了关于tepotinib在分子水平作用机制的关键见解.
相关概念视频
Protein Kinases and Phosphatases
13.2K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.2K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Receptor Tyrosine Kinases
13.1K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
13.1K


